PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40126F19019Precisionfda o&m support — Dnanexus, Inc

Dnanexus, Inc holds $17.0M across 11 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 2 related awards under parent 75F40119D10041. Recompete timing centers on the May 27, 2027 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs

Awarding office

Dnanexus, Inc

Recipient

May 27, 2027

PoP end

$3.7M

Obligated

$3.7M

Potential

518210

NAICS

DA01

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Dnanexus, Inc — $90

Contract facts

Federal

Contract number75F40126F19019

Also listed as75F40119D10041-75F40126F19019

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentDnanexus, Inc

CAGE5KNP1

UEID3WLJYBFS2M3

NAICS518210

No full NAICS 518210 intel page yet. Browse NAICS intelligence

PSCDA01

Parent IDIQ / IDV75F40119D10041

Place of performanceROCKVILLE MD

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition After Exclusion Of Sources

PoP startMay 28, 2026

PoP end (current)May 27, 2027

Obligated$3.7M

Current value$3.7M

Potential value$3.7M

PRECISIONFDA O&M SUPPORT is a federal award for Fda Office Of Acq Grant Svcs held by Dnanexus, Inc. Estimated value $3.7M ($3.7M obligated). Current period of performance ends May 27, 2027. Place of performance: ROCKVILLE MD.

Recompete timing

Public

● Expiring in 262 days

Current PoP ends May 27, 2027 (262 days remaining). Agencies typically plan 12–18 months ahead — at 8.6 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Dnanexus, Inc — $17.0M obligated across 11 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$17.0M · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

75F40124F19015

PRECISIONFDA PUBLIC INSTANCE OF GSRS O&M

$2.4M

Sep 5, 2027

75N91024P00555

DNANEXUS PLATFORM AS A SERVICE (PAAS) FOR A CLOUD-BASED DATA ANALYSIS AND MANAGEMENT PLATF…

$380K

Sep 8, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40126F19019?

75F40126F19019 (Precisionfda o&m support) is a Fda Office Of Acq Grant Svcs award with a potential value of $3.7M, currently held by Dnanexus, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40126F19019?

Fda Office Of Acq Grant Svcs awarded 75F40126F19019 to Dnanexus, Inc (potential $3.7M).

Who is the incumbent on 75F40126F19019?

Dnanexus, Inc is the incumbent with $17.0M across 11 related awards in SCOUT’s public footprint. The current period of performance ends May 27, 2027.

When does Dnanexus, Inc’s 75F40126F19019 come up for recompete?

SCOUT tracks a period-of-performance end of May 27, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75F40126F19019 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action May 21, 2026